| Autor: |
Mota SM; Veterinary Department, Royal Zoological Society of Scotland (RZSS), Edinburgh Zoo, Edinburgh, EH12 6TS, United Kingdom, smota@rzss.org.uk., Girling SJ; Veterinary Department, Royal Zoological Society of Scotland (RZSS), Edinburgh Zoo, Edinburgh, EH12 6TS, United Kingdom., Cole G; Veterinary Department, Royal Zoological Society of Scotland (RZSS), Edinburgh Zoo, Edinburgh, EH12 6TS, United Kingdom., Brown D; Veterinary Department, Royal Zoological Society of Scotland (RZSS), Edinburgh Zoo, Edinburgh, EH12 6TS, United Kingdom., Johnson G; OLM Diagnostics, Newcastle upon Tyne, NE4 5TF, United Kingdom., Naylor AD; Veterinary Department, Royal Zoological Society of Scotland (RZSS), Edinburgh Zoo, Edinburgh, EH12 6TS, United Kingdom. |
| Abstrakt: |
Aspergillosis is the primary fungal disease affecting captive penguins globally. Its diagnosis remains challenging, and currently no tests are both sensitive and specific for the detection of early infection. The present study evaluated a recently developed Aspergillus lateral-flow device (AspLFD) for the detection of Aspergillus spp. antigen in plasma and glottis mucus from captive penguins. In a pilot retrospective study, banked frozen plasma samples from captive penguins were reviewed: samples from 11 gentoo penguins ( Pygoscelis papua papua ) and 4 king penguins ( Aptenodytes patagonicus ) fulfilled the inclusion criteria and were used in the analysis. Positive plasma AspLFD test results were found in 80% (four of five) of the aspergillosis-positive cases tested. All of the aspergillosis-negative cases tested negative (10 of 10) on the AspLFD test. In a cohort prospective study, paired plasma and glottis swab samples were opportunistically and nonrandomly collected from captive gentoo penguins. In total, 26 penguins were tested. In the negative control group, AspLFD test was negative on plasma and swab in 100% of birds (14 of 14). In the aspergillosis-positive group, AspLFD test was positive on plasma samples from 33% (4 of 12) of birds, on swab samples from 50% (6 of 12) of birds, and on either plasma or swab samples from 75% (9 of 12) of birds. The AspLFD is currently used for the diagnosis of aspergillosis in humans and also shows promise for use in penguins. Larger prospective studies are recommended. |
